Literature DB >> 19504464

NMR metabolomics and drug discovery.

Robert Powers1.   

Abstract

NMR is an integral component of the drug discovery process with applications in lead discovery, validation, and optimization. NMR is routinely used for fragment-based ligand affinity screens, high-resolution protein structure determination, and rapid protein-ligand co-structure modeling. Because of this inherent versatility, NMR is currently making significant contributions in the burgeoning area of metabolomics, where NMR is successfully being used to identify biomarkers for various diseases, to analyze drug toxicity and to determine a drug's in vivo efficacy and selectivity. This review describes advances in NMR-based metabolomics and discusses some recent applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504464     DOI: 10.1002/mrc.2461

Source DB:  PubMed          Journal:  Magn Reson Chem        ISSN: 0749-1581            Impact factor:   2.447


  28 in total

1.  Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.

Authors:  Steven Halouska; Robert J Fenton; Raúl G Barletta; Robert Powers
Journal:  ACS Chem Biol       Date:  2011-12-01       Impact factor: 5.100

2.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

Review 3.  Glutathione, glutathione S-transferase, and glutathione conjugates, complementary markers of oxidative stress in aquatic biota.

Authors:  Jocelyne Hellou; Neil W Ross; Thomas W Moon
Journal:  Environ Sci Pollut Res Int       Date:  2012-04-25       Impact factor: 4.223

Review 4.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

5.  NMR Metabolomics Protocols for Drug Discovery.

Authors:  Fatema Bhinderwala; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

6.  Automated annotation and quantification of metabolites in 1H NMR data of biological origin.

Authors:  Erik Alm; Tove Slagbrand; K Magnus Aberg; Erik Wahlström; Ingela Gustafsson; Johan Lindberg
Journal:  Anal Bioanal Chem       Date:  2012-02-24       Impact factor: 4.142

Review 7.  Analysis of bacterial biofilms using NMR-based metabolomics.

Authors:  Bo Zhang; Robert Powers
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

8.  Analysis of metabolomic PCA data using tree diagrams.

Authors:  Mark T Werth; Steven Halouska; Matthew D Shortridge; Bo Zhang; Robert Powers
Journal:  Anal Biochem       Date:  2009-12-21       Impact factor: 3.365

9.  Evaluating line-broadening factors on a reference spectrum as a bucketing method for NMR based metabolomics.

Authors:  Bo Wang; Antoniette M Maldonado-Devincci; Lin Jiang
Journal:  Anal Biochem       Date:  2020-07-29       Impact factor: 3.365

10.  Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice.

Authors:  P Matthew Joyner; Ronni M Matheke; Lindsey M Smith; Robert H Cichewicz
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.